AKORN FDA Approval ANDA 204055

ANDA 204055

AKORN

FDA Drug Application

Application #204055

Application Sponsors

ANDA 204055AKORN

Marketing Status

Prescription001

Application Products

001SOLUTION/DROPS;OPHTHALMIC0.05%0EPINASTINE HYDROCHLORIDEEPINASTINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-05-05

Submissions Property Types

ORIG1Null17

TE Codes

001PrescriptionAT

CDER Filings

AKORN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204055
            [companyName] => AKORN
            [docInserts] => ["",""]
            [products] => [{"drugName":"EPINASTINE HYDROCHLORIDE","activeIngredients":"EPINASTINE HYDROCHLORIDE","strength":"0.05%","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/05\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-05-05
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.